CKD-330 Drug-Drug Interaction Study (Candesartan)

NCT02064621 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Candesartan 32mg
DRUG: Candesartan 32mg/Amlodipine 10mg

Sponsor

Chong Kun Dang Pharmaceutical